Han; Wen-Ching
Patent Applications and Registrations
Patent applications and USPTO patent grants for Han; Wen-Ching.The latest application filed is for "5h-pyrido[3,2-b]indole compounds as anticancer agents".
Company Profile
1.24.22
- Han; Wen-Ching - Newtown PA
- Han; Wen-Ching - Newton PA
- Han; Wen-Ching - Holland PA
Patent Activity
| Patent | Date |
|---|---|
| 5H-pyrido[3,2-B]indole compounds as anticancer agents Grant 10,174,024 - Han , et al. J | 2019-01-08 |
| 5h-pyrido[3,2-b]indole Compounds As Anticancer Agents App 20180093983 - HAN; Wen-Ching ; et al. | 2018-04-05 |
| Tricyclic compounds as anticancer agents Grant 9,751,879 - Norris , et al. September 5, 2 | 2017-09-05 |
| Tricyclic compounds as anticancer agents Grant 9,725,449 - Norris , et al. August 8, 2 | 2017-08-08 |
| Tricyclic Compounds As Anticancer Agents App 20160333013 - Norris; Derek J. ; et al. | 2016-11-17 |
| Carbazole compounds useful as bromodomain inhibitors Grant 9,492,460 - Poss , et al. November 15, 2 | 2016-11-15 |
| Novel Tricyclic Compounds As Anticancer Agents App 20160326173 - Norris; Derek J. ; et al. | 2016-11-10 |
| Tricyclic Compounds As Anticancer Agents App 20160318928 - Norris; Derek J. ; et al. | 2016-11-03 |
| Novel Tricyclic Compounds As Anticancer Agents App 20160176864 - Norris; Derek J. ; et al. | 2016-06-23 |
| Prodrugs of 1,4-benzodiazepinone compounds Grant 9,273,075 - Gavai , et al. March 1, 2 | 2016-03-01 |
| N-substituted bis(fluoroalkyl)-1,4-benzodiazepinone compounds Grant 9,242,940 - Han , et al. January 26, 2 | 2016-01-26 |
| Alkyl, fluoroalkyl-1,4-benzodiazepinone compounds Grant 9,242,941 - Gavai , et al. January 26, 2 | 2016-01-26 |
| Fluoroalkyl-1,4-benzodiazepinone compounds Grant 9,133,139 - Gavai , et al. September 15, 2 | 2015-09-15 |
| N-substituted Bis(fluoroalkyl)-1,4-benzodiazepinone Compounds App 20150246892 - Han; Wen-Ching ; et al. | 2015-09-03 |
| Alkyl, Fluoroalkyl-1,4-benzodiazepinone Compounds App 20150239851 - Gavai; Ashvinikumar V. ; et al. | 2015-08-27 |
| Fluoroalkyl And Fluorocycloalkyl 1,4-benzodiazepinone Compounds App 20150231152 - Zhao; Yufen ; et al. | 2015-08-20 |
| Prodrugs Of 1,4-benzodiazepinone Compounds App 20150232491 - Gavai; Ashvinikumar V. ; et al. | 2015-08-20 |
| Fluoroalkyl-1,4-benzodiazepinone Compounds App 20150218111 - Gavai; Ashvinikumar V. ; et al. | 2015-08-06 |
| Carbazole Compounds Useful As Bromodomain Inhibitors App 20140256700 - Poss; Michael A. ; et al. | 2014-09-11 |
| Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function Grant 8,067,582 - Norris , et al. November 29, 2 | 2011-11-29 |
| Pyrrolotriazine Compounds As Kinase Inhibitors App 20110039838 - Fink; Brian E. ; et al. | 2011-02-17 |
| Fused Heterocyclic Compounds Useful As Modulators Of Nuclear Hormone Receptor Function App 20100331324 - Norris; Derek J. ; et al. | 2010-12-30 |
| Pyrrolotriazine compounds as kinase inhibitors Grant 7,846,931 - Fink , et al. December 7, 2 | 2010-12-07 |
| Pyrrolotriazine Compounds As Kinase Inhibitors App 20090048244 - Fink; Brian E. ; et al. | 2009-02-19 |
| Alkylene bridged sultam compounds useful as modulators of nuclear hormone receptor function Grant 7,468,439 - Shan , et al. December 23, 2 | 2008-12-23 |
| Fused tricyclic compounds as inhibitors of 17.beta.-hydroxysteroid dehydrogenase 3 Grant 7,417,040 - Fink , et al. August 26, 2 | 2008-08-26 |
| Fused heterotricyclic compounds as inhibitors of 17.beta.-hydroxysteroid dehydrogenase 3 Grant 7,378,426 - Gavai , et al. May 27, 2 | 2008-05-27 |
| Alkylene Bridged Sultam Compounds Useful As Modulators Of Nuclear Hormone Receptor Function App 20080090883 - Shan; Weifang ; et al. | 2008-04-17 |
| Pyrrolotriazine compounds as kinase inhibitors Grant 7,297,695 - Fink , et al. November 20, 2 | 2007-11-20 |
| Pyrrolotriazine compounds Grant 7,151,176 - Gavai , et al. December 19, 2 | 2006-12-19 |
| Pyrrolotriazine compounds as kinase inhibitors Grant 7,141,571 - Fink , et al. November 28, 2 | 2006-11-28 |
| Pyrrolotriazine Compounds As Kinase Inhibitors App 20060264438 - Fink; Brian E. ; et al. | 2006-11-23 |
| Di-substituted pyrrolotriazine compounds Grant 7,064,203 - Gavai , et al. June 20, 2 | 2006-06-20 |
| Pyrrolotriazine compounds App 20060089358 - Gavai; Ashvinikumar V. ; et al. | 2006-04-27 |
| Fused tricyclic compounds as inhibitors of 17beta-hydroxysteroid dehydrogenase 3 App 20050250753 - Fink, Brian E. ; et al. | 2005-11-10 |
| Di-substituted pyrrolotrizine compounds App 20050197339 - Gavai, Ashvinikumar V. ; et al. | 2005-09-08 |
| Fused heterotricyclic compounds as inhibitors of 17beta-hydroxysteroid dehydrogenase 3 App 20050192310 - Gavai, Ashvinikumar V. ; et al. | 2005-09-01 |
| Pyrrolotriazine compounds as kinase inhibitors App 20050182058 - Fink, Brian E. ; et al. | 2005-08-18 |
| Aminothiazole inhibitors of cyclin dependent kinases App 20020137778 - Kim, Kyoung S. ; et al. | 2002-09-26 |
| Aminothiazole inhibitors of cyclin dependent kinases Grant 6,262,096 - Kim , et al. July 17, 2 | 2001-07-17 |
| Aminothiazole inhibitors of cyclin dependent kinases Grant 6,040,321 - Kim , et al. March 21, 2 | 2000-03-21 |
| Prostaglandin analogs Grant 5,827,868 - Misra , et al. October 27, 1 | 1998-10-27 |
| Heterocyclic thrombin inhibitors Grant 5,741,792 - Kimball , et al. April 21, 1 | 1998-04-21 |
| Heterocyclic thrombin inhibitors Grant 5,741,799 - Kimball , et al. April 21, 1 | 1998-04-21 |
| Heterocyclic thrombin inhibitors Grant 5,583,146 - Kimball , et al. December 10, 1 | 1996-12-10 |
| Modified guanidino and amidino thrombin inhibitors Grant 5,561,146 - Kim , et al. October 1, 1 | 1996-10-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 